Researchers from the Indian Institute of Technology Madras (IIT Madras) and Ohio State University have developed an advanced artificial intelligence framework that replicates real-world chemical synthesis to accelerate drug discovery.
Drug Discovery | 06/11/2025 | By Darshana
Syngene International Invests in Peptide Laboratory and Advanced Automation
Syngene International has set up a dedicated peptide laboratory equipped with advanced automation technologies to accelerate hit-to-lead timelines. The investment enhances the company’s integrated drug discovery and development capabilities, reinforcing its position as a leading partner for end-to-end research solutions.
Drug Discovery | 16/10/2025 | By Dineshwori
IRBM Expands Functional Genomics Platform to Boost Early Drug Discovery
The platform integrates CRISPR-based methodologies, screening capabilities, cell engineering, and advanced molecular and cellular analysis to drive both target discovery and validation.
Drug Discovery | 05/04/2025 | By Aishwarya | 239
TME Pharma Partners with aimed analytics for AI-Driven Drug Discovery and Optimization
This partnership supports TME Pharma's strategic plan, announced on December 4, 2024, by enhancing its capability profile for potential strategic partners.
Drug Discovery | 30/01/2025 | By Aishwarya | 573
NVIDIA Teams Up with Industry Leaders to Accelerate Genomics and Drug Discovery
Healthcare leaders IQVIA, Illumina and Mayo Clinic, as well as Arc Institute, are using the latest NVIDIA technologies to develop solutions that will help advance human health.
Drug Discovery | 15/01/2025 | By Aishwarya | 340
Acellera Rolls Out AceForce 1.0 to Advance Drug Discovery
AceForce 1.0 is a groundbreaking tool in computational chemistry and drug discovery, offering quantum-level accuracy by leveraging a proprietary training set of millions of quantum mechanical (QM) calculations.
Drug Discovery | 08/01/2025 | By Aishwarya | 330
Axcelead DDP Signs Drug Discovery Service Deal with Astellas for Targeted Protein Degraders
Under the agreement, Axcelead DDP will support Astellas’ targeted protein degrader discovery utilizing DegLeadTM Platform and contribute to the generation of breakthrough new drug candidate compounds.
Drug Discovery | 27/12/2024 | By Aishwarya | 203
Ono and Congruence to Generate Novel Small Molecule Correctors in Oncology Area
Under the terms of the agreement, Congruence will generate small molecule correctors by leveraging Congruence's proprietary drug discovery engine called, Revenir™.
Drug Discovery | 07/12/2024 | By Aishwarya | 307
Parallel Fluidics Secures USD 7 Million Seed Round to Boost Microfluidic Development
The funding will help drive the growth of the company's on-demand design and manufacturing platform, expand its hardware and software solutions, and commercialize its new product, MV-2.
Drug Discovery | 08/11/2024 | By Aishwarya | 257
Kvantify Launches New Computational Method for Drug Discovery
The method stands out significantly from other solutions on the market and is a strong addition to Kvantify's computational drug discovery platform, Koffee.
Drug Discovery | 14/10/2024 | By Aishwarya | 263
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy